Oaktree Capital Management Provides Debt Refinancing to Innocoll
Innocoll Biotherapeutics, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, successfully refinanced its existing term loan facility with a $125 million term loan provided by funds managed by Oaktree Capital Management.
January 31, 2022
Aman Kumar | Gurnet Point Capital | Innocoll Biotherapeutics | Louis Pascarella | Oaktree Capital Management
Ian Koplin